These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2435639)

  • 1. [Quality parameters of cryoprecipitates from stored blood preservation].
    Schlaack P; Weippert M; Wilms K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):716-9. PubMed ID: 2435639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased yield of F VIII from pooled plasma vs. single-donor plasma in the production of cryoprecipitates.
    Rácz Z; Thék M; Jánossy A; Pintér J; Baróti C
    Arch Med Res; 1997; 28(2):179-82. PubMed ID: 9204605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Self-sufficiency with factor VIII in Norway. Use of freeze-dried cryoprecipitates instead of purified factor VIII concentrates].
    Solheim BG; Evensen SA; Stavem P; Glomstein A
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):16-8. PubMed ID: 3082031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stability of blood coagulation factors in deep frozen fresh plasma by storage at -20 degrees C and -40 degrees C].
    Koerner K; Stampe D
    Infusionsther Klin Ernahr; 1984 Feb; 11(1):46-50. PubMed ID: 6706385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight.
    Cardigan R; Lawrie AS; Mackie IJ; Williamson LM
    Transfusion; 2005 Aug; 45(8):1342-8. PubMed ID: 16078924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Further experimental studies on preparations following a modified method of factor VIII (AHG) isolation by freeze precipitation. II].
    Wegner H; Bergmann A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):320-6. PubMed ID: 4195276
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood.
    Solheim BG; Bergerud UE; Kjeldsen-Kragh J; Brosstad F; Mollnes TE; Högman CF; Eriksson L; Schutz R
    Vox Sang; 1998; 74(3):168-75. PubMed ID: 9595644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The preparation and use of cryoprecipitates].
    Roewer J; Wilms K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(4):496-506. PubMed ID: 4184476
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the procurement of blood coagulation factor VIII: effects of plasma freezing rate and storage conditions on cryoprecipitate quality.
    Farrugia A; Prowse C
    J Clin Pathol; 1985 Apr; 38(4):433-7. PubMed ID: 3921572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved thaw-siphon method for the cryoprecipitate preparation.
    Kang EP
    Vox Sang; 1980; 38(3):172-7. PubMed ID: 6770544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma factor VIII, variables affecting stability under standard blood bank conditions and correlation with recovery in concentrates.
    Pepper MD; Learoyd PA; Rajah SM
    Transfusion; 1978; 18(6):756-60. PubMed ID: 726024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation-related effects on the coagulation activity of plasma].
    Schmitt H
    Beitr Infusionsther; 1989; 24():91-4. PubMed ID: 2481554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Occurrence and behavior of fibrin fibrinogen degradation products in concentrates of factor VIII, cryoprecipitate and dextran precipitate during long-term preservation].
    Kätzel R; Wegner H
    Z Gesamte Inn Med; 1977 Nov; 32(22):603-11. PubMed ID: 602311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stability of blood coagulation factors in plasma frozen 6 and 18 hours after blood collection].
    Kellner S; Stöcker U; Fürst G
    Infusionsther Klin Ernahr; 1985 Aug; 12(4):208-10. PubMed ID: 4066006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factor VIII preparations of varying purity-examination of physico-chemical parameters (author's transl)].
    Vukovich T; Koller E; Doleschel W; Mayr WR
    Wien Klin Wochenschr; 1980; 92(11):385-91. PubMed ID: 6775418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of factors affecting the stability of frozen heparinized plasma.
    Palmer DS; Rosborough D; Perkins H; Bolton T; Rock G; Ganz PR
    Vox Sang; 1993; 65(4):258-70. PubMed ID: 8310678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freezing of plasma and recovery of factor VIII.
    Carlebjörk G; Blombäck M; Pihlstedt P
    Transfusion; 1986; 26(2):159-62. PubMed ID: 3082044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deformability of human red blood cells stored for different periods at subzero temperatures.
    Wegner G; Kucera W; Toursel W; Lerche D
    Biomed Biochim Acta; 1987; 46(7):599-603. PubMed ID: 3426571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.